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Abstract
Background—BisGMA-based dental composites may release bisphenol A (BPA). Our purpose 
was to assess changes in urinary BPA concentrations over 6-months follow-up in children and 
adolescents receiving bisGMA-based restorations.
Methods—We collected urine and interviewed parents/guardians for BPA-related exposure 
information before and approximately one-day, 14-days, and 6-months post-treatment among 91 
participants aged 3–17 years needing composite restorations. We used multivariable linear 
regression models to test associations between number of surface-restorations placed and changes 
in urinary BPA concentrations.
Results—Participants had on average 1.4 (sd=1.0) surfaces filled with composite at the first 
treatment visit and a cumulative 2.3 (sd=1.6) surfaces filled during the study. Mean change in BPA 
between pretreatment and next-day was 1.71 ng/mL (sd=9.94) overall and 0.87 (sd=5.98) after 
excluding one participant with 8 surfaces filled at the visit. Overall, a greater number of composite 
surface-restorations placed was associated with higher BPA in the next-day sample (posterior-
occlusal eβ=1.47, 95% CI 1.18–1.83; P<0.001), but this was attenuated after restricting to the 88 
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participants with ≤4 fillings (eβ=1.19, 95% CI 0.86, 1.64), and no association was observed using 
14-day (eβ=0.94, 95% CI 0.75–1.18) or 6- month (eβ=0.88, 95% CI 0.74–1.04) samples.
Conclusions—Placement of bisGMA-based restorations in children and adolescents may 
produce transient increases in urinary BPA concentration, which are no longer detectable 
approximately 14-days or 6-months post-treatment in urine samples. When few restorations are 
placed, increases in urinary BPA concentrations may not be detectable owing to high inter-
individual variation in BPA exposure.
Practical Implications—These results suggest that leaching of BPA from newly placed 
composites ceases being detectable in urine within 2 weeks of restoration placement. The potential 
human health impact of such short-term exposure remains uncertain.
Keywords
Dental restoration; Dental care for children; Composites; Pediatric dentistry; Polymers; Bisphenol 
A
INTRODUCTION
Bisphenol A (BPA) is a chemical used in the manufacturing of polycarbonate plastics and 
epoxy resins that are used by nearly every industry, including dentistry. Concern over human 
BPA exposure exists because BPA is an endocrine disrupting chemical, and animal studies 
show that BPA has reproductive, developmental, and systemic toxic effects even at low 
doses (e.g., <50 mg/kg/day).1–3 A causal role for BPA in human health problems remains to 
be determined, and most studies to date have been cross-sectional.4,5 However, evidence 
from prospective human studies suggests that prenatal or postnatal exposure to BPA is 
associated with reproductive health measures (e.g. ovarian toxicity in women,6 delayed 
puberty in boys7), and immune function8,9 and neurodevelopment in children.4
The possibility of adverse effects of BPA exposure in humans has driven research efforts to 
identify BPA exposure sources, improve BPA exposure characterization in humans, and 
produce BPA-free substitute products.10,11 The predominant exposure route in the general 
population appears to be through foods and beverages manufactured and stored using BPA-
containing materials.12–17 However, such products account for only ~20% of the BPA 
produced worldwide each year,11 and human biomonitoring studies suggest that non-dietary 
exposure sources also exist.18,19
In dentistry, BPA is used to synthesize matrix monomers, such as bisphenol A glycidyl 
dimethacrylate (bisGMA), that are commonly used in composite restorative and sealant 
materials.20 The BPA structure has benefits of bulk, rigidity and strength.21 An unfavorable 
feature of such composite materials is incomplete polymerization, which results in 
shrinkage, marginal leakage, and degradation over time.21,22 Numerous studies have shown 
that composite materials release various chemicals, including BPA, while in the oral 
environment.23–25 The largest human biomonitoring study of this issue to date included 172 
adults followed for a maximum of 30 h after receiving composite restorations. The study 
reported increases in BPA and other related compounds in saliva within 1 h after restoration 
placement, and an increased concentration of BPA in urine 9–30 h after placement.26 
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However, the time window of chemical release from composite restorations may extend past 
this initial placement period, throughout the life of the restoration, as the composite degrades 
over time.24 In vitro studies indicate that storage time, as well as mechanical stress such as 
chewing, and acidic food/beverage, are associated with release of chemical components of 
composite.24,27,28 The extent to which BPA continues to be released over the long-term 
remains unexamined in human biomonitoring studies. Even if very low dose (<no-observed-
adverse-effect-level) as suggested by in vitro studies,22 the possible chronic exposure may 
have an impact on health outcomes, as low levels of endocrine disrupting chemicals are 
sufficient for adverse effects in animal studies.2,29
The possibility of adverse health effects of composites was suggested in the New England 
Children’s Amalgam Trial (NECAT), a 5-year clinical trial designed to test the safety of 
dental amalgam for restorations: Children who were randomly assigned treatment with 
composite had worse psychosocial health outcomes after 4–5 years compared to children 
randomized to amalgam.30 Further analysis showed that greater treatment level of composite 
restorations containing bisGMA was associated with increased behavioral problems, certain 
neuropsychological measures, and, possibly, certain immune function markers.31–33 
However, randomization to composite was not associated with altered physical 
development,34 and there was no association between preventive sealants or other flowable 
composite materials and psychosocial or neuropsychological health.35 While the dental 
materials used in the trial have been shown to release BPA, bisGMA and related 
materials,36–39 the trial did not measure changes in children’s urinary concentrations of BPA 
or other compounds that may leach from composite. Thus, it remains uncertain the extent to 
which composite restorations lead to BPA exposure in children.
The aim of this study was to examine changes in urinary BPA concentrations in children and 
adolescents before and after placement of dental composite restorations, up to 6 months 
post-treatment.
METHODS
The Composites and Urinary Bisphenol-a Study (CUBS) was a clinical study designed to 
examine changes in urinary BPA concentration in pediatric dental patients after placement of 
dental composite restorations over approximately 6 months follow-up. Figure 1 outlines the 
enrollment eligibility criteria and data collection visits. Study participants were recruited 
from 8 participating clinical sites in the greater Boston area: two academic hospital settings 
(Tufts University School of Dental Medicine; Franciscan Hospital for Children), three 
community health centers (Cambridge Health Alliance; Lynn Community Health Center; 
Edward M. Kennedy Community Health Center), two private practices, and one oral health 
research institute (The Forsyth Institute). The study was approved by a central institutional 
review board (IRB) and each participating institutional IRB, including the IRB of the 
independent research organization, New England Research Institutes, Inc. The analysis of 
blinded specimens by the Centers for Disease Control and Prevention (CDC) laboratory was 
determined not to constitute engagement in human subjects research. Written informed 
consent was obtained from the parent or legal guardian of participants, and signed assent 
was obtained from participants of appropriate age. Recruitment occurred February 2012 
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through December 2013, and follow-up visits were completed in June 2014. A total of 113 
patients were enrolled, of which 91 had at least one pre-treatment and one post-treatment 
urine sample and were therefore included in statistical analyses.
Urine Sample Data Collection and Laboratory Methods
After enrollment, each parent/guardian completed a baseline interview with a data collector, 
who then provided a polypropylene urine cup and instructions on collecting a first morning 
urine sample. The instructions stated that parents should try to avoid having the participant 
eat canned foods or drinks the day before collecting urine and provided step-by-step 
directions for collecting, handling, and refrigerating urine samples if the first morning void 
occurred prior to the arrival of the data collector. Two data collectors scheduled and 
conducted all urine sample collection visits, generally at the participant’s home. Data 
collectors obtained urine samples at two pretreatment visits and at three post-treatment 
visits, scheduled to occur next morning, 14 days and 6 months approximately after 
restoration placement (Figure 1). Of the two pretreatment samples, one was collected on the 
morning of the restoration placement, and the other was collected in the morning one to 
seven days prior to the treatment to ensure availability of at least one pretreatment sample 
and to allow analysis of the within-person variability of BPA pretreatment. For participants 
who needed more than one treatment visit to have all composite restorations placed, we 
requested additional urine sample collections the next morning and approximately 14 days 
after each additional treatment visit, with up to 7 post-treatment urine samples collected per 
participant.
Data collectors transported each urine sample in a cooler to the processing area, where they 
brought the sample to room temperature, aliquotted it into Nalgene® cryovials using a 
sterile polypropylene pipette, and measured specific gravity using a calibrated refractometer 
(Atago 4410 PAL-10S). Samples were then stored at −86 °C unPl shipment to the CDC 
(Atlanta, GA). Staff members at the CDC performed laboratory assays to quantify the 
concentration of total (free plus conjugated) species of urinary BPA using a modification of 
the automated online solid-phase extraction-high performance liquid chromatography-
isotope-dilution tandem mass spectrometry approach previously described.40 The limit of 
detection (LOD) was 0.1 ng/mL.
At each urine collection visit, the data collector conducted a brief interview, which included 
a 24 h food recall with probes for canned foods and use of plastic containers to gather 
information on recent possible BPA exposure sources. The final urine sample collection 
visit, which occurred approximately 6 months after the last treatment visit, marked the end 
of active study participation.
Dental Materials and Data Collection
We aimed to standardize the dental materials and restoration placement procedures for study 
participants across clinical sites. To be consistent with NECAT, the standard treatment 
materials were Z100 restorative (3M ESPE, St. Paul, MN) with Optibond bonding agent 
(Kerr, Orange, CA). Both materials contain bisGMA among other compounds. Similar to 
many other bisGMA-containing composite restoratives, the composite restorative has been 
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previously shown to release BPA and bisGMA.24,36–39 If patients needed sealants placed 
while enrolled in the study, the standard sealant was Embrace (Pulpdent, Watertown, MA), 
which contains no bisGMA or related compounds. All treatments and materials were used 
according to manufacturers’ indications. For each dental visit that occurred between the first 
study-related composite restoration until the patient’s final 6-month urine sample collection, 
we collected data on the type of treatments received, tooth surfaces treated, rubber dam 
usage, and manufacturers/brands of materials used. Because participants may have had 
composites and sealants already in place prior to the first study-related treatment, the dentist 
recorded the number of existing restored or sealed surfaces and material types present at 
baseline.
Statistical Analysis
We calculated descriptive statistics for BPA concentrations at each visit. BPA concentrations 
were log-normally distributed, therefore, we loge transformed concentrations prior to further 
analysis. One sample had a BPA concentration below LOD; for this sample, we used LOD/
√2.41 We corrected BPA concentrations (ng/mL) for specific gravity to account for variations 
in urine dilution.42 The primary dependent variable was change from baseline in log-
transformed BPA concentration corrected for specific-gravity. For patients who provided two 
pre-treatment urine samples, we used the geometric mean of the two samples, each corrected 
for specific gravity, to obtain the baseline BPA concentration.43 We calculated the intraclass 
correlation coefficient (ICC) to examine the temporal reproducibility of the two measures, 
by dividing the estimate of between subject variance by the estimated total variance. For 
patients who provided just one pre-treatment sample, the BPA concentration corrected for 
specific gravity was used as the baseline BPA concentration.
The analysis included 91 participants who provided at least one pretreatment urine sample, 
had at least one composite restoration newly placed, and provided at least one post-treatment 
urine sample. Preliminary analyses included descriptive statistics on the change in urinary 
BPA concentration from pretreatment to each post-treatment visit. In the main analyses, the 
primary independent variable was the total number of surfaces restored with composite 
while on-study. A secondary measure was the number of posterior occlusal surfaces restored 
on-study. We used multivariable linear regression models to estimate the association 
between composite treatment levels and change in BPA concentration from baseline to each 
follow-up time point (next-day, 14-day, and 6-months post-treatment) separately. We 
assessed several sociodemographic, dietary and other factors as potential predictors of BPA 
concentration based on the published literature.13,14,44–46 Potential predictors of BPA 
exposure considered as covariates in the models included: age, race/ethnicity, sex, body 
mass index, parent/guardian education, household income, presence of orthodontic dental 
materials, presence of dental sealants or composites at baseline, urine collection time, 
location of urine sample storage prior to processing, and consumption of canned food, foods 
microwaved in plastic, or foods and beverages in plastic containers within 24h of the urine 
sample. Participants missing data on a potential confounder were included using an indicator 
category for missing in that variable. We ran regression models for change in BPA with each 
potential covariate; variables for which P<0.2 were entered into a single multivariable 
model, which we then reduced to retain only variables for which P remained <0.2. The final 
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models adjusted for baseline BPA concentration and household income as fixed variables, 
and canned food consumption in the day prior to urine sample collection and the season of 
urine sample collection as time-varying variables. The exponentiated beta coefficients 
represent the percent change in urinary-BPA concentration from the pretreatment geometric 
mean associated with each composite surface placed.
The sample size had 80% power to detect a difference of 0.3 standard deviations using 
paired t-tests to compare urinary BPA values before and at various time points after the first 
dental treatment. As few participants had additional treatment visits and provided additional 
next-day or 14-day urine samples, analyses of pre/post changes in next day or 14 days after 
additional treatments were exploratory. For example, 26 participants in the analysis provided 
80% power to detect a difference of 0.6 standard deviations. In the regression models, 
statistical significance was tested at level 0.05. All analyses were conducted using SAS v9.3 
(Cary, NC).
RESULTS
Figure 1 provides a flow chart of the number of patients enrolled and urine sample 
collections pre-treatment and during follow-up. Approximately half (N=49/91, 53.8%) of 
participants had a single visit with composite placement. Of the participants who had 
additional composite placement visits and provided additional urine samples, the median 
time between the first and second treatment was 21 days, and between the first and third 
treatment was 37 days. The final urine sample collection occurred at a median of 162 days 
and mean 170 (sd=32) days, or approximately 5.7 months after treatment.
At baseline, study participants were on average 9.5 years old (sd=3.7) and represented a 
diverse patient population in race/ethnicity, body size, and parental education level (Table 1). 
Use of plastic containers for drinking was common, with over two-thirds reporting use on 
some or most days. Few participants (n=14) reported canned food consumption in the day 
prior to the pretreatment urine collection. Data on the number of restorations and sealants 
present at baseline were available for 63 (69.2%) of participants, of which 39 (42.9%) had 
composite restorations and 35 (38.5%) had sealants present.
Dental Treatment
At the first treatment visit, most participants (68.5% of the 89 with treatment 1) had only one 
surface filled, while 23.6% had two surfaces, 6.7% had 3 or 4 surfaces, and one patient 
(1.1%) had 8 surfaces filled, resulting in a mean 1.4 (sd 1.0) surfaces filled at this visit 
(Table 2). Over the course of the study, including participants who required additional 
treatment visits, the mean number of surfaces filled was 2.3 (sd=1.6, N=91). Overall, 43.9% 
of participants had one surface filled with composite, 25.3% had two surfaces, 17.6% had 
three surfaces, 8.8% had four surfaces, 2.2% (n=2) had six surfaces, and 2.2% (n=2) had 
eight composite surface-restorations placed. Most filled surfaces were posterior occlusal 
surfaces; both the mean and median number of posterior-occlusal surfaces filled during the 
study were 2.0 (sd 1.4). Z100 restorative was used in 93.4% of participants (n=85/91). A 
rubber dam was used for at least one filling in 51.6% of participants. Twenty participants 
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had sealants placed during the course of the study, of which 16 (80%) used Embrace 
material.
Urinary BPA Concentration
Pretreatment, the median BPA concentration unadjusted for specific gravity was 1.98 ng/mL, 
with 75th percentile 3.80 ng/mL and 95th percentile 8.28 ng/mL. Corrected for specific 
gravity, the geometric mean (sd) pretreatment BPA concentration was 3.32 ng/mL (sd=3.80, 
min=0.43, max=23.41 ng/mL, N=91 participants). Among participants who had two pre-
treatment samples (N=84), there was a statistically significant correlation between the two 
measures of BPA (P=0.02), with an intraclass correlation coefficient of 0.25. There was no 
association between the number of pre-existing composite restorations and changes in BPA 
concentration over follow-up (data not shown).
Table 2 provides the mean change in BPA from baseline to each follow-up visit. Compared 
to baseline, the mean BPA concentration was increased next-day post-treatment 1 (mean 
change 1.71 ng/mL, sd=9.94, P=0.11, n=89 participants) and treatment 3 (mean change 1.97 
ng/mL, sd=2.91, P=0.36, n=3 participants), but not treatment 2 (mean change −0.59 ng/mL, 
sd=3.62, P=0.41, n=26 participants). The next-day group mean BPA concentration of 5.04 
ng/mL [sd=10.11, min=0.56, max=81.8] corresponds to a 51.4% increase in the baseline 
group mean of 3.33 ng/mL.
In the multivariable linear regression model (Table 3), a greater number of surfaces filled 
with composite at treatment 1 was associated with a greater change in urinary BPA 
concentration the next day (P=0.002 for all surfaces, P<0.001 for posterior occlusal 
surfaces), but not in the 14-day or 6-month samples. For each surface placed, a 37% increase 
in geometric mean BPA concentration would be expected, controlling for other predictors of 
BPA change.
In sensitivity analysis, we explored the impact of participants with the highest number of 
surfaces restored. The participant with 8 surfaces restored in a single visit had a considerably 
higher BPA concentration the day after treatment (81.8 ng/mL) compared to other 
participants (mean 4.17 ng/mL, range 0.56–35.1 ng/mL). Seven of the 8 surfaces were 
poster-occlusal surfaces. The participant reported no canned food consumption within the 
day prior to the urine sample collections and was not missing data on any covariates 
included in the models. Excluding this participant, the mean change in BPA was 0.87 ng/mL 
(sd=5.98), and the association between number of composite-restored surfaces and next-day 
change was attenuated (multivariable-adjusted eβ=1.19, P=0.29 for posterior occlusal 
surfaces, eβ=1.08, P=0.57 for all surfaces). Another participant accumulated 8 surface 
fillings across three visits, at the last of which two surfaces were filled, and the next-day 
BPA concentration was increased by 0.71 ng/mL from baseline. At the final visit 
approximately 6 months later, both of these participants had BPA concentrations (1.52 
ng/mL and 1.30 ng/mL) close to the median pretreatment value (2.12 ng/mL).
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This study found that placement of a higher number of composites in children and 
adolescents was associated with a greater increase in urinary BPA concentrations one day 
after treatment, but there was no detectable increase at approximately 14 days or 6 months 
after treatment, or when few restorations were placed. Adjusting for other predictors of 
urinary-BPA concentration, each posterior-occlusal composite-surface restoration was 
associated with a 47% increase next-day in the geometric mean baseline value, but the 
association was attenuated to 19% when we excluded the only participant to have a 
considerably higher number of 8 surfaces filled in a single visit. Given that an increase in 
mean BPA concentration was no longer detectable approximately 14 days or 6 months later, 
the findings of this study do not support the hypothesis that dental composites remain a 
measurable BPA exposure source after a brief period post-placement in children and 
adolescents.
CUBS is the first study designed to examine BPA exposure from dental composites over the 
longer term. It is also the first longitudinal study including a sufficient sample size of 
children and adolescents. Prior studies focused on the first 24–30 h after placement in adults. 
We focused on children and adolescents for multiple reasons, including (a) findings from the 
NECAT that children randomized to composites (vs. amalgam) and with higher numbers of 
composite restorations performed worse on certain neuropsychosocial outcome measures 
after 4–5 years follow-up;30–33 (b) data from numerous countries that children and 
adolescents had higher urinary BPA concentrations compared to adults, with little 
understanding as to the exposure sources or metabolic differences that may account for age-
related differences,46–48 and (c) knowledge that dental restorations are most frequently 
placed at younger ages.49 In the US, more than 60% of 5–19 year olds have dental caries or 
restorations present.49
The finding of a 51% increase in the overall mean BPA concentration the day after 
restoration placement is consistent with results in adults from a prior study, which showed a 
43% increase in the overall mean urinary BPA concentration 9 to 30 hours after composite 
restoration placement.26 Also, despite the different ages, the pretreatment BPA 
concentrations were similar in the two studies. Data from the US National Health and 
Nutrition Examination Survey (NHANES) show that in recent years, BPA concentrations 
have declined more among the population aged 6–19 y than among adults, bringing 
reference values closer for the different age groups.44,48,50 Our observed distribution of 
pretreatment BPA concentrations was within the range for reference values reported for 6–11 
year olds and 12–18 year olds in the 2011–2012 NHANES.48 In NHANES, children with ≥7 
restorations had 20% higher mean urinary BPA concentration compared to children with no 
restorations (95% CI: −6, 53; P=0.13).51 However, NHANES did not have data on 
restorative material type, hence combined amalgam, glass ionomer and other materials with 
bisGMA-based composites, and other limitations in the cross-sectional design weakened the 
ability to detect an association with bisGMA-based materials.51,52 In a meta-analysis of in 
vitro studies of dental materials, it was estimated that one full crown molar restoration may 
release an average 57.4 nmol of BPA per surface after 24 h, which implicated composites 
alongside contaminated food (~43.8 nmol) as a relevant BPA source.24 Thus, the observation 
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of a mean 43–51% increase in pretreatment BPA concentration within approximately one 
day post-treatment supports the notion that placement of composite dental materials may 
expose the patient, albeit transiently, to BPA.
Our lack of finding a longer-term association between composite placement and BPA 
concentrations supports the American Dental Association (ADA) 2014 statement that most 
residual BPA in bisGMA-based materials is probably locked inside the polymer matrix after 
polymerization.22 The ADA’s in vitro analyses of various bisGMA-based composite 
restoratives using artificial saliva highlighted the importance of polymerization in the first 48 
h.22 Although composites are cured during placement, polymerization remains incomplete. 
Thus, the mechanism of BPA exposure during and shortly after placement is thought to 
involve leaching of non-polymerized components. In an in vitro study using dynamic 
mechanical analysis to experiment with various mechanical and environmental stressors on 
three different composite restoration material over 90 days, the researchers found that 
storage in water or artificial saliva for 1 to 7 days caused post-curing reactions, but storage 
for 30 or 90 days had no further effect for two of the three materials.53 Together, these 
results support the notion that leaching of non-polymerized components of newly-placed 
composite materials terminates after a few days to a few weeks from the start of 
polymerization during treatment.28
The question remains whether degradation of composite restorations, typically occurring 
over a course of many years after placement, results in chronic, low levels of BPA exposure. 
The CUBS follow-up time of approximately 6 months post-treatment was too short to 
include the typical life span of restorations including degradation, which may extend well 
over 10–20 years for current materials.54 In addition, few participants had more than one 
treatment visit during follow-up, and the sample sizes were not sufficient for hypothesis 
testing after each additional treatment visit. As such, changes in BPA concentration next-day 
or 14-days after treatment 2 or treatment 3 were analyzed as exploratory analysis, and results 
were presented for completeness rather than to draw conclusions.
The consistency in dental materials used in CUBS and NECAT was intended to help explore 
changes in urinary BPA as a possible source for health outcomes observed in NECAT. 
However, the ability to generalize from CUBS participants to NECAT participants, or to 
patients receiving multiple surface fillings in one visit, was limited by the low treatment 
needs in CUBS participants. In NECAT, children had an average of 9.3 surfaces with caries 
at the first dental examination, whereas the average was only 2.3 surfaces in CUBS.31 The 
results of both studies point to the possibility of dose-response relationships, but the CUBS 
data were insufficient to thoroughly examine high treatment levels, as few participants had 
more than 3 surfaces filled. Given that the most striking increase in next-day urinary BPA 
concentration was in a patient with 8 surfaces filled in a single visit, it is possible that for the 
majority of patients who received just one or two surface fillings, changes in BPA 
concentrations were not measurable in the context of high inter-individual variation. That is, 
large variation in BPA may decrease the power to detect very small changes associated with 
dental treatment. Furthermore, while only two CUBS participants had more than 7 surfaces 
restored on-study (2.2%), 21.3% of the children in a published NHANES analysis51 had 7 or 
more restorations (maximum=42). As such, the patient sample in CUBS was not suitable to 
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examine associations with the high levels of composite treatment that may often occur in the 
general population. It remains uncertain if children receiving more than three fillings in one 
visit have a greater increase and/or extended release over time in BPA concentration.
High within-person variability in urinary BPA concentration and BPA’s short half-life (~6 h 
through oral route)55 are problematic in long-term studies, as single spot samples may be 
dramatically affected by acute exposures, such as food consumption.56 Given this 
knowledge, we took numerous steps to in both our design and analysis to strengthen our 
ability to detect an association with composite placement. First, we considered non-dental 
BPA exposure sources. For example, we requested participants refrain from consuming 
canned foods and collected detailed data on foods/beverages consumed and preparation 
methods in the day prior to each urine collection. In the analysis, canned food consumption 
and season of urine collection were indeed time-varying predictors of urinary BPA changes. 
Second, we collected two pretreatment urine samples, which allowed us to evaluate baseline 
variability. The ICC of 0.25 was consistent with results of other studies of urinary BPA 
concentration in children57 or adults.58,59 A study of Australian children found that a single 
sample provided moderately reliable assessment of BPA exposure in children, with 68% of 
individuals correctly classified by a single sample, and 76% correctly classified by 2 
samples.60 Third, we followed recommendations from prior studies to request standardized 
timing (first morning) of collections, record the time of day and handling of samples, and 
measure urine dilution using specific gravity.42,58
In conclusion, placement of composite restorations in children and adolescents was 
associated with transient increases in urinary BPA concentration, which were no longer 
detectable at approximately 2 weeks or 6 months post-placement or after excluding study 
participants receiving high number of fillings in a single visit. The magnitude of change in 
BPA may depend on the number of surfaces restored, and additional research would be 
needed to precisely estimate such changes among children with more than 3 surfaces filled 
in one visit. It is unlikely that pre-existing composite restorations or sealants are measurable 
BPA exposure sources, but further research would be necessary particularly for failed 
restorations or degradation of restorations over their lifespan. Given that the human health 
effects of BPA remain to be determined, this study was not designed to directly affect 
clinical practice. Nonetheless, dentists should be aware of possible concerns regarding BPA 
exposure and take steps to prevent exposure during and shortly after treatment, such as 
improved methods for curing.61 Alternatives to bisGMA-based materials are increasing 
available, in part owing to concerns over BPA.21 For comprehensive safety and benefit-risk 
assessments, more information would be needed on human health effects of BPA and 
alternatives, as the benefits of composite restorations are well-established.
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Patient Eligibility Criteria and Flow through Study Visits
*Additional visits were not required by the study protocol, but some participants had 
additional treatment visits to complete their composite treatment needs. Such participants 
were asked, but not required, to provide additional next-day and 14-day urine samples after 
each additional treatment visit (scheduled to occur approximately 2–3 weeks apart). For 
participants with multiple visits, the final urine sample collection was scheduled to occur 
approximately 6 months after the final restoration treatment visit.
†Includes 40 par0cipants who received composite at the first treatment, and 2 par0cipants 
who a2ended the first visit but did not receive composite restorations until the 2nd visit.
‡Includes 9 children who received composite at all 3 visits, and the 2 par0cipants who 
received composite restorations only at visits 2 and 3.
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Table 1
Baseline Characteristics of CUBS Participants in the Analysis (N=91)*
Age, years, mean (sd) 9.5 (± 3.7)
Sex
 Male 47 (53.4%)
 Female 41 (46.6%)
Race/Ethnicity
 Hispanic 35 (38.5%)
 White 24 (26.4%)
 Black 16 (17.6%)
 Other/missing 16 (17.6%)
Body mass index, kg/m2, mean (sd) 19.6 (± 6.0)
Education level of parent/guardian
 No high school diploma 18 (20.7%)
 High school graduate 30 (34.5%)
 College graduate or above 39 (44.8%)
Household income
 < $20,000 21 (23.1%)
 $20,000-$50,000 21 (23.1%)
 $50,000+ 22 (24.2%)
 Missing 27 (29.7%)
Frequency of drinking from plastic containers
 Almost every day 37 (42.0%)
 Some days 23 (26.1%)
 Never 28 (31.8%)
Consumed canned food in the previous 24 h
 No 77 (84.6%)
 Yes 14 (15.4%)
Composite restorations present
 Missing data 28 (30.8%)
 No 24 (26.4%)
 Yes 39 (42.9%)
  Mean (SD) 3.4 (4.2)
  Median (Q1, Q3) 2 (1, 4)
Sealants (preventive pit and fissure) present
 Missing data 28 (30.8%)
 No 28 (30.8%)
 Yes 35 (38.5%)
  Mean (SD) 3.8 (2.4)
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  Median (Q1, Q3) 4 (2, 6)
Plastic space maintainers present
 No 86 (95.6%)
 Yes 4 (4.4%)
BPA concentration specific-gravity adjusted (ng/mL)
 Mean (SD) 3.32 (3.80)
 Median (min, max) 2.12 (0.43, 23.41)
*
Percentages are calculated excluding participants missing data from the denominator, except for race/ethnicity, household income, composite 
restorations present, and sealants present. Missing data at baseline for other variables were as follows: sex n= 3; education level n=4, drinking from 
plastic containers n=3, plastic space maintainers present, n=1. The total sample size (N=91) is comprised of 89 participants treated with composite 
at the first visit and 2 participants who had no composite treatment at that visit but received composite at visits 2 and 3.
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